As 2025 gets underway, reconnecting with key accounts is top of mind for many. For oncology drug manufacturers, having the right tools to navigate these conversations is critical. That’s where our Integrated Delivery Network (IDN) Dataset comes in, providing the insights and clarity you need to drive meaningful engagement with 147 unique IDNs.
What Makes the IDN Dataset Stand Out?
The dataset includes comprehensive demographic and process data tailored to help you better understand and connect with IDNs, including:
This online dashboard enables you to anticipate and address the needs of IDN stakeholders effectively.
Key Features at Your Fingertips
Our IDN-at-a-Glance Dashboard, accessible via our online portal, simplifies preparation for account teams by offering:
Now Available in Snowflake
We’ve enhanced accessibility by making our dataset available in Snowflake.
Looking Ahead
As IDNs face increasing complexity in oncology management, having a strategic approach backed by actionable insights is critical. Our dataset doesn’t just offer data—it equips your teams with the tools to anticipate challenges and seize opportunities.
Have questions? Reach out to our team or learn more about the portal with our IDN dataset overview! Send me a note at ebijesse@hmpglobal.com.
Ashu is the glue that keeps our team organized and running smoothly. This year, he’s been particularly fascinated by the growing consolidation among community practices and how it’s reshaping the oncology landscape.
Ashutosh ShethCAR T-cell and BsAb therapies are powerful but largely confined to AMCs, limiting patient access. Our latest report explores how expanding to community oncology could improve access, addressing key clinical, logistical, and financial challenges.
Chris Van DenburgNot only does Emma have over a decade of experience supporting academic health systems and integrated delivery networks (IDNs), but she’s also the go-to for a delicious apple pie.
Emma Bijesse